Effect of lidoflazine on coronary circulation and myocardial metabolism in anesthetized and unanesthetized dogs.
D000758:Anesthesia; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D003331:Coronary Vessels / Q000187:drug effects*; D004176:Dipyridamole / Q000494:pharmacology*; D004285:Dogs; D005260:Female; D005263:Femoral Artery; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects*; D007275:Injections, Intravenous; D007773:Lactates / Q000097:blood; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D010084:Oxidation-Reduction; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects*; D010879:Piperazines / Q000008:administration & dosage / Q000494:pharmacology*; D011773:Pyruvates / Q000097:blood; D012039:Regional Blood Flow / Q000187:drug effects*; D013268:Stimulation, Chemical; D013997:Time Factors; D014665:Vasodilator Agents / Q000494:pharmacology*; D014992:Xylenes
D007773:Lactates; D010879:Piperazines; D011773:Pyruvates; D014665:Vasodilator Agents; D014992:Xylenes; D004176:Dipyridamole; D010100:Oxygen